Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Crenier

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Haematology|December 1, 1996
Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitorL Crenier, J Ducobu, J M des Grottes, et al.
Acta Clinica Belgica|January 1, 1997
A case of rapidly fatal systemic capillary leak syndrome in a kidney transplant recipientL Crenier, M Piagnerelli, J M Doutrelepont, et al.
British Journal of Haematology|June 1, 1997
All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemiaA Kentos, F Le Moine, L Crenier, et al.
Bone Marrow Transplantation|October 23, 1997
Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrierE Schneider, M Lambermont, J P Van Vooren, et al.
Diabetologia|August 10, 2004
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidenceI Weets, L Kaufman, B Van der Auwera, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Diabetologia|May 29, 2013
In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactionsE Mbunwe, B J Van der Auwera, I Weets, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Haematology|December 1, 1996
Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitorL Crenier, J Ducobu, J M des Grottes, et al.
Acta Clinica Belgica|January 1, 1997
A case of rapidly fatal systemic capillary leak syndrome in a kidney transplant recipientL Crenier, M Piagnerelli, J M Doutrelepont, et al.
British Journal of Haematology|June 1, 1997
All-trans retinoic acid induced thrombocytosis in a patient with acute promyelocytic leukaemiaA Kentos, F Le Moine, L Crenier, et al.
Bone Marrow Transplantation|October 23, 1997
Autologous stem cell infusion for acute myeloblastic leukemia in an HIV-1 carrierE Schneider, M Lambermont, J P Van Vooren, et al.
Diabetologia|August 10, 2004
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidenceI Weets, L Kaufman, B Van der Auwera, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Diabetologia|May 29, 2013
In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactionsE Mbunwe, B J Van der Auwera, I Weets, et al.
Pageof 2